CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells.

MLA

Storci, Gianluca, et al. “CAR+ Extracellular Vesicles Predict ICANS in Patients with B Cell Lymphomas Treated with CD19-Directed CAR T Cells.” The Journal of Clinical Investigation, vol. 134, no. 14, June 2024. EBSCOhost, https://doi.org/10.1172/JCI173096.

APA

Storci, G., De Felice, F., Ricci, F., Santi, S., Messelodi, D., Bertuccio, S. N., Laprovitera, N., Dicataldo, M., Rossini, L., De Matteis, S., Casadei, B., Vaglio, F., Ursi, M., Barbato, F., Roberto, M., Guarino, M., Asioli, G. M., Arpinati, M., Cortelli, P., … Bonifazi, F. (2024). CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells. The Journal of Clinical Investigation, 134(14). https://doi.org/10.1172/JCI173096

Chicago

Storci, Gianluca, Francesco De Felice, Francesca Ricci, Spartaco Santi, Daria Messelodi, Salvatore Nicola Bertuccio, Noemi Laprovitera, et al. 2024. “CAR+ Extracellular Vesicles Predict ICANS in Patients with B Cell Lymphomas Treated with CD19-Directed CAR T Cells.” The Journal of Clinical Investigation 134 (14). doi:10.1172/JCI173096.